Viewing Study NCT06492902



Ignite Creation Date: 2024-07-17 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06492902
Status: RECRUITING
Last Update Posted: 2024-07-11
First Post: 2024-07-01

Brief Title: Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic Dermatitis
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City
Organization: University of Medicine and Pharmacy at Ho Chi Minh City

Study Overview

Official Title: Efficacy of Adding Auricular Acupuncture to Xiao-Feng-San for Treating Atopic Dermatitis Exhibiting Wind-Dampness-Heat Manifestations According to Traditional Medicine A Multi-Center Double-Blinded Randomized Sham-Controlled Trial
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to compare the efficacy of adding auricular acupuncture to Xiao-Feng-San decoction versus Xiao-Feng-San decoction in treating atopic dermatitis The trial is a multi-center double-blinded randomized sham-controlled study
Detailed Description: Atopic dermatitis AD is a chronic inflammatory skin condition that affects a significant number of individuals worldwide In Traditional Medicine TM Xiao-Feng-San XFS a TM formula has been widely used in the treatment of mild to moderate AD exhibiting wind-dampness-heat manifestations This study aims to investigate whether the addition of auricular acupuncture AA a form of acupuncture targeting points on the ear enhances the efficacy of XFS in treating AD

The trial is a multi-center double-blinded randomized sham-controlled study involving participants diagnosed with mild to moderate AD exhibiting wind-dampness-heat manifestations according to TM and indicated for the use of XFS decoction Participants will be randomly assigned to receive either AA or sham AA placebo in addition to XFS Outcome measures will include the severity of AD symptoms quality of life assessments the need for antipruritic medication total serum immunoglobulin E IgE levels and adverse effects

Through rigorous methodology and blinding procedures this study seeks to provide evidence on the comparative efficacy of adjunct AA in enhancing the therapeutic effects of XFS for AD The findings aim to contribute valuable insights into optimizing treatment strategies for AD using integrative approaches

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None